Deep Track Capital, LP Allakos Inc. Transaction History
Deep Track Capital, LP
- $2.27 Billion
- Q4 2024
A detailed history of Deep Track Capital, LP transactions in Allakos Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 5,704,282 shares of ALLK stock, worth $1.65 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
5,704,282
Previous 5,000,000
14.09%
Holding current value
$1.65 Million
Previous $3.25 Million
112.37%
% of portfolio
0.3%
Previous 0.12%
Shares
7 transactions
Others Institutions Holding ALLK
# of Institutions
79Shares Held
68.8MCall Options Held
20.9KPut Options Held
0-
Bvf Inc San Francisco, CA16.6MShares$4.8 Million0.75% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$1.78 Million0.53% of portfolio
-
Lynx1 Capital Management LP San Juan, PR3.63MShares$1.05 Million1.7% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.59MShares$1.04 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$994,1600.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $24.6M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...